Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00704197 · ClinicalTrials.gov registry record
"ISIS" Study of Sex Differences in Characteristics of Adiposity and Metabolism
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Terminated
- Registry status
- 23
- Enrollment target
NCT00704197: Clinical Trial study, sponsored by Pennington Biomedical Research Center.
NCT00704197 is a clinical trial that was terminated before completion, run by Pennington Biomedical Research Center. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00704197 was terminated before completion, sponsored by Pennington Biomedical Research Center.
- TERMINATED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize differences in the structure and function of the body fat from two different parts of the body in young, healthy men and women. We will also compare how differences in metabolism relate to characteristics of body fat and its functions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2007-08 |
| Est. Completion | 2016-01 |
Why NCT00704197 stopped before completion
NCT00704197 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00704197 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00704197 about?
NCT00704197 is a clinical study titled ""ISIS" Study of Sex Differences in Characteristics of Adiposity and Metabolism". The purpose of this study is to characterize differences in the structure and function of the body fat from two different parts of the body in young, healthy men and women. We will also compare how differences in metabolism relate to characteristics of body fat and its functions.
What is the current status of trial NCT00704197?
This trial is currently terminated. The enrollment target is 23 participants. The study started on 2007-08. Estimated completion is 2016-01.
Who is sponsoring clinical trial NCT00704197?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia